Mesa Laboratories, Inc.

57
Hold
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US59064R1095
USD
95.10
0.15 (0.16%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Mesa Laboratories, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
12.00
5.00
-275.00
0.00
3.00
2.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-4.00
6.00
5.00
-17.00
-7.00
5.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
42.00
46.00
44.00
27.00
39.00
37.00
Cash Flow from Investing Activities
-3.00
-4.00
-81.00
-9.00
-305.00
-1.00
Cash Flow from Financing Activities
-41.00
-44.00
32.00
-33.00
52.00
146.00
Net Cash Inflow / Outflow
0.00
0.00
-4.00
-16.00
-214.00
182.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
1.00
1.00
0.00
-1.00
-1.00
1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Mesa Laboratories, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
12.014
28.361
-16.00
-57.64%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-4.987
-4.345
0.00
-14.78%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
42.831
24.947
18.00
71.69%
Cash Flow from Investing Activities
-3.25
-8.421
5.00
61.41%
Cash Flow from Financing Activities
-41.854
-17.601
-24.00
-137.79%
Net Cash Inflow / Outflow
-0.393
-1.075
1.00
63.44%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
1.88
0
1.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'26
stock-summary

YoY Growth in year ended Mar 2026 is -8.50% vs 6.06% in Mar 2025

Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
42.83
46.81
-8.50%